Advertisement
The American College of Cardiology

Updated Guidelines Released for Ventricular Arrhythmias

0
Guidelines for VA, sudden cardiac death include evaluation, testing, treatment, prevention strategies
The Centers for Medicare & Medicaid Services has launched an initiative to examine which provider regulations should be discarded or revamped amid concerns that the regulations are reducing the amount of time that physicians spend with patients

CMS Launches Initiative to Examine Impact of Regulations

0
Officials set to travel country gathering information on impact of their regulations on physicians
Aspirin resistance

PFA-100-Measured Aspirin Resistance Linked to CV Events

0
Strong correlation between aspirin resistance, CV events at 5-year follow-up in aspirin-treated patients
Depressive symptoms increase during the internship year for training physicians

Depressive Symptoms Increase During Internship Year

0
Significantly greater increase seen among women; sex disparity partly due to work-family conflict
Rates of systemic lupus erythematosus (SLE) mortality have decreased since 1968 but are still higher than non-SLE mortality

Systemic Lupus Erythematosus Mortality Down Since 1968

0
However, SLE mortality is still higher than non-SLE mortality; sex, racial, regional disparities exist
Percutaneous coronary intervention (PCI) of the culprit lesion is associated with better 30-day outcomes than immediate multivessel PCI among patients with multivessel coronary artery disease and acute myocardial infarction with cardiogenic shock

Culprit-Lesion-Only PCI Tied to Improved 30-Day Outcomes

0
Linked to lower risk of mortality compared to multivessel PCI in patients with acute MI and multivessel CAD
Primary care providers and medical homes have a role to play in the management of pediatric patients with congenital heart disease and their families

PCP Has Vital Role in Managing Pediatric Heart Disease

0
New American Academy of Pediatric policy statement details care guidelines for congenital heart disease
A combination of clinical factors and payer type increase the likelihood of approval for proprotein convertase subtilisin/kexin type 9 inhibitor treatment

Rate of Approval for PCSK9i Therapy 47 Percent

0
Clinical factors and payer type linked to likelihood of approval, with highest approval for Medicare
Overall

More Than One in Five U.S. Working Adults Uses Tobacco

0
4.6 percent report current use of two or more products; highest use for construction workers
Increased arterial stiffness

Arterial Stiffness Linked to Incidence of Diabetes

0
Increased risk of diabetes across increasing tertiles of carotid-femoral pulse wave velocity